ARE THERE ANY PARTICULARITIES IN CROHN'S DISEASE IN NORTH-EASTERN ROMANIA?

Authors

  • Mihaela DRANGA University of Medicine and Pharmacy "Grigore T. Popa"- Iasi
  • Catalina MIHAI University of Medicine and Pharmacy "Grigore T. Popa"- Iasi
  • Otilia GAVRILESCU University of Medicine and Pharmacy "Grigore T. Popa"- Iasi
  • Cristina CIJEVSCHI-PRELIPCEAN University of Medicine and Pharmacy "Grigore T. Popa"- Iasi

Abstract

Crohn’s disease is an inflammatory disease of the gastro-intestinal tract with an evolution marked by activity and remission periods. Lately, the incidence and evolution models of Crohn’s disease significantly changed, an increasing number of patients presenting more severe forms. The aim of the study is to analyze Crohn’s disease in its phenotypic classification and to establish correlation between the localization, the behavior and the activity of Crohn’s disease. Material and methods: A transversal study on 53 patients with Crohn’s disease was conducted. Results: from the 53 patients, 56.6% were males, 85% from the urban areas. Under the phenotype aspect, the colonic localization (49.1%) and the inflammatory behavior (52.8%) were predominant. More severe forms of activity were discovered to patients with ileal localization (57.1%) or with penetrant phenotype (33.3%). Conclusions: Male patients from urban areas were predominant. The most frequent forms are the colonic and ileocolonic forms. From a behavioral point of view, we observed an obvious predominance of the inflammatory phenotype. The moderate - severe activity was predominant for the ileal localization and the mild - moderate activity for the colonic and ileocolonic localization. A mild-moderate activity is present for the stenosing forms and a moderate -severe one for the penetrant forms.

Author Biographies

  • Mihaela DRANGA, University of Medicine and Pharmacy "Grigore T. Popa"- Iasi

    Faculty of Medicine
    Department of Medical Specialties (I)
    Institute of Gastroenterology and Hepathology Iași

  • Catalina MIHAI, University of Medicine and Pharmacy "Grigore T. Popa"- Iasi

    Faculty of Medicine
    Department of Medical Specialties (I)
    Institute of Gastroenterology and Hepathology Iași

  • Otilia GAVRILESCU, University of Medicine and Pharmacy "Grigore T. Popa"- Iasi

    Faculty of Medicine
    Department of Medical Specialties (I)
    Institute of Gastroenterology and Hepathology Iași

  • Cristina CIJEVSCHI-PRELIPCEAN, University of Medicine and Pharmacy "Grigore T. Popa"- Iasi

    Faculty of Medicine
    Department of Medical Specialties (I)
    Institute of Gastroenterology and Hepathology Iași

References

1. Lees CW, Barrett JC, Parkes M, Satsangi J. New IBD genetics: common pathways with other diseases. Gut 2011; 60: 1739-1753.
2. Nedelciuc O, Pintilie I, Dranga M, Mihai C, Prelipcean CC. Quality of life in patients with ulcerative colitis. Rev Med Chir Soc Med Nat Iasi 2012; 116(3): 756-760.
3. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterol 2012; 142: 46-54.
4. Mihai C, Cijevschi Prelipcean C, Pintilie I. Nutrition in inflammatory bowel diseases Rev Med Chir Soc Med Nat Iasi 2013; 117(3): 662-669.
5. Miheller P, Kiss LS, Juhasz M, et al. Recommendations for identifying Crohn’s disease patients with poor prognosis. Expert Rev Clin Immunol. 2013; 9: 65-75.
6. Gasche C, Scholmerich J, Brynskov J, et al A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000; 6(1): 8-15.
7. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005; 19(Suppl A): 5A-36A.
8. Brant S R, Panhuysen C I, Bailey‐Wilson J E. et al Linkage heterogeneity for the IBD1 locus in Crohn's disease pedigrees by disease onset and severity. Gastroenterol 2000; 119: 1483-1490.
9. Rioux J D, Silverberg M S, Daly M J. et al Genomewide search in Canadian families with inflamma-tory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 2000; 66(6): 1863-1870.
10. Russell R K, Drummond H E, Nimmo E E. et al Genotype‐phenotype analysis in childhood‐onset Crohn's disease: NOD2/CARD15 variants consistently predict phenotypic characteristics of severe disease. Inflamm Bowel Dis 2005; 1(11): 955-964.
11. Sandborn WJ, Feagan BG, Hanauer SB, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterol. 2002; 122: 512-530
12. Henriksen M, Jahnsen J, Lygren I,et al. Clinical course in Crohn's disease: results of a five-year popu-lation-based follow-up study (the IBSEN study). Scand J Gastroenterol 2007; 42(5): 602-610.
13. S Shivananda, J Lennard-Jones, R Logan, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996; 39(5): 690-697.
14. Lewis BS. Expanding role of capsule endoscopy in inflammatory bowel disease. World J Gastroenterol 2008; 14(26): 4137-4141.
15. Louis E, Collard A, Oger AF, et al. Behaviour of Crohn’s disease according to the Vienna classifica-tion: changing pattern over the course of the disease. Gut 2001; 49: 777-782.
16. V. Chouraki, G. Savoye, L. Dauchet, et al. The changing pattern of Crohn’s disease incidence in northern France: a continuing increase in the 10- to 19-year-old age bracket (1988-2007). Aliment Pharmacol Ther 2011; 33: 1133-1142.

Additional Files

Published

2015-06-30

Issue

Section

INTERNAL MEDICINE - PEDIATRICS